Zoungas S, et al. Lancet Diabetes Endocrinol 2026; 14: 544–557
A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial
Grandangolo in Nefrologia, Dialisi e Trapianto
Newsletter
©Accademia Nazionale di Medicina | Provider ECM Nazionale N° 31 | Tutti i diritti riservati | Webmaster | Privacy policy | Powered by Forum Service